The constitutively active BCR-Abl tyrosine kinase is the product of the reciprocal translocation of chromosomes 9 and 22 and the causative oncoprotein in over 95% of chronic myeloid leukemia (CML) cases [1]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.